These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16569586)

  • 41. EBV-associated perianal Hodgkin's disease in an HIV-positive individual.
    Sapp M; Perez-Ordonez B; Brenneman F; Imrie K; Morava-Protzner I; Lim MS
    Am J Hematol; 2001 Jan; 66(1):42-5. PubMed ID: 11426491
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Epstein-Barr virus and Hodgkin's lymphoma].
    Hjalgrim H; Munksgaard L; Melbye M
    Ugeskr Laeger; 2002 Dec; 164(50):5924-7. PubMed ID: 12553111
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The molecular pathogenesis of classical Hodgkin lymphoma].
    Mathas S; Dörken B; Janz M
    Dtsch Med Wochenschr; 2009 Sep; 134(39):1944-8. PubMed ID: 19760557
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The molecular basis for the generation of Hodgkin and Reed-Sternberg cells in Hodgkin's lymphoma.
    Lee IS; Kim SH; Song HG; Park SH
    Int J Hematol; 2003 May; 77(4):330-5. PubMed ID: 12774919
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular pathogenesis of Hodgkin's lymphoma: increasing evidence of the importance of the microenvironment.
    Steidl C; Connors JM; Gascoyne RD
    J Clin Oncol; 2011 May; 29(14):1812-26. PubMed ID: 21483001
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic susceptibility to Hodgkin's lymphoma associated with the human leukocyte antigen region.
    Diepstra A; Niens M; te Meerman GJ; Poppema S; van den Berg A
    Eur J Haematol Suppl; 2005 Jul; (66):34-41. PubMed ID: 16007866
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The biological basis of Hodgkin's lymphoma.
    Horie R; Watanabe T
    Drug News Perspect; 2003 Dec; 16(10):649-56. PubMed ID: 14747844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recent insights into the biology of Hodgkin lymphoma: unraveling the mysteries of the Reed-Sternberg cell.
    Roullet MR; Bagg A
    Expert Rev Mol Diagn; 2007 Nov; 7(6):805-20. PubMed ID: 18020910
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dimeric procyanidin B2 inhibits constitutively active NF-kappaB in Hodgkin's lymphoma cells independently of the presence of IkappaB mutations.
    Mackenzie GG; Adamo AM; Decker NP; Oteiza PI
    Biochem Pharmacol; 2008 Apr; 75(7):1461-71. PubMed ID: 18275936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epstein-Barr virus-associated proliferative disorder presenting as Hodgkin's lymphoma and developing as aggressive natural killer-cell leukemia 19 years later: a case report of composite lymphoma.
    Oka K; Nagayama R; Mori N
    Pathol Res Pract; 2009; 205(10):730-4. PubMed ID: 19269751
    [TBL] [Abstract][Full Text] [Related]  

  • 51. NF-κB deregulation in Hodgkin lymphoma.
    Weniger MA; Küppers R
    Semin Cancer Biol; 2016 Aug; 39():32-9. PubMed ID: 27221964
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
    Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
    Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inflammation: gearing the journey to cancer.
    Kundu JK; Surh YJ
    Mutat Res; 2008; 659(1-2):15-30. PubMed ID: 18485806
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients.
    Diepstra A; van Imhoff GW; Schaapveld M; Karim-Kos H; van den Berg A; Vellenga E; Poppema S
    J Clin Oncol; 2009 Aug; 27(23):3815-21. PubMed ID: 19470931
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between Epstein-Barr virus LMP-1 and Hodgkin lymphoma LMP-1 mechanisms in Hodgkin lymphoma development.
    Oliveira LOD; Costa IB; Quaresma JAS
    Rev Med Virol; 2024 Jul; 34(4):e2561. PubMed ID: 38877989
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidemiology and pathologic features of Hodgkin lymphoma.
    Nakatsuka S; Aozasa K
    Int J Hematol; 2006 Jun; 83(5):391-7. PubMed ID: 16787868
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NF-kappaB inhibitors induce lytic cytotoxicity in Epstein-Barr virus-positive nasopharyngeal carcinoma cells.
    Liu SF; Wang H; Lin XC; Xiang H; Deng XY; Li W; Tang M; Cao Y
    Cell Biol Int; 2008 Aug; 32(8):1006-13. PubMed ID: 18579417
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Recent advances in molecular pathology of classic Hodgkin's lymphoma].
    An G; Chen HS; Qiu LG
    Zhonghua Bing Li Xue Za Zhi; 2010 Feb; 39(2):133-6. PubMed ID: 20388387
    [No Abstract]   [Full Text] [Related]  

  • 59. Hodgkin's lymphoma and its association with EBV and HIV infection.
    Grewal R; Irimie A; Naidoo N; Mohamed N; Petrushev B; Chetty M; Tomuleasa C; Abayomi EA
    Crit Rev Clin Lab Sci; 2018 Mar; 55(2):102-114. PubMed ID: 29316828
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of tumor necrosis factor alpha and infliximab on apoptosis of B lymphocytes infected or not with Epstein-Barr virus.
    Baran-Marszak F; Laguillier C; Youlyouz I; Feuillard J; Mariette X; Fagard R; Raphaël M
    Cytokine; 2006 Mar; 33(6):337-45. PubMed ID: 16713282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.